Cargando…
VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases
Research on vaccines against trypanosomatids, a family of protozoa that cause neglected tropical diseases, such as Chagas disease, leishmaniasis, and sleeping sickness, is a current need. Today, according to modern vaccinology, virus-like particle (VLP) technology is involved in many vaccines, inclu...
Autores principales: | Queiroz, Aline Maria Vasconcelos, Oliveira, Johny Wysllas de Freitas, Moreno, Cláudia Jassica, Guérin, Diego M. A., Silva, Marcelo Sousa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998750/ https://www.ncbi.nlm.nih.gov/pubmed/33807516 http://dx.doi.org/10.3390/vaccines9030220 |
Ejemplares similares
-
Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs
por: Branco Santos, Joice Castelo, et al.
Publicado: (2020) -
Application of Dithiocarbamates as Potential New Antitrypanosomatids-Drugs: Approach Chemistry, Functional and Biological
por: Oliveira, Johny Wysllas de Freitas, et al.
Publicado: (2019) -
Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma cruzi
por: de Freitas Oliveira, Johny Wysllas, et al.
Publicado: (2021) -
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
por: Prates-Syed, Wasim A., et al.
Publicado: (2021) -
Variable Surface Glycoprotein from Trypanosoma brucei Undergoes Cleavage by Matrix Metalloproteinases: An in silico Approach
por: Moreno, Cláudia Jassica Gonçalves, et al.
Publicado: (2019)